Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHellenic Dynamics Regulatory News (HELD)

  • This share is currently suspended. It was suspended at a price of 0.95

Share Price Information for Hellenic Dynamics (HELD)

Share Price is delayed by 15 minutes
Get Live Data
0.95    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.40m
HELD Live PriceLast checked at - London Stock Exchange

Intraday Hellenic Dynamics Share Chart

Further re: Winding-Up Petition

12 Feb 2025 17:45

RNS Number : 9193W
Hellenic Dynamics PLC
12 February 2025
 

12 February 2025

 

Hellenic Dynamics plc

 

("Hellenic Dynamics" or the "Company")

 

Further re: Winding-Up Petition

 

Hellenic Dynamics Plc (LSE: HELD), a medical cannabis cultivator focussed on producing medical cannabis flowers for global markets announces that further to the announcement made earlier today the petition issued by Tomasz Dulak for the winding up of the Company was granted notwithstanding the Directors producing affidavits that the Company had never dealt with the Petitioner in any capacity and that his claim was based upon losses that he had personally incurred whilst speculatively trading in the Company's shares. 

The Directors have taken immediate action to have the judgement set aside for the reasons set out above and are confident that their application will be granted. 

In their announcement of earlier today the Directors said that:

"They do not believe that the Company is responsible for re-imbursing the petitioner for the losses that he is claiming given he is not a trade creditor of the Company and is looking to recover, from the Company, losses that he suffered by reason of speculative trading of its shares."

and they confirm that this remains their considered belief based upon the fact that, prior to Mr Dulak threatening to issue proceedings, there had been no communication between him and the Company in any form and that the Court's decision was made in error.

The Directors also announce that the Company's discussions regarding approaches that it has received in relation to the Company's re-financing are progressing. 

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

 

The Directors of the Company take responsibility for this announcement.

 

Enquires:

 

Hellenic Dynamics Plc

Davinder Rai

+44 (0)7469845941

info@hellenicdynamics.com

 

Cairn Financial Advisers LLP

Emily Staples / Jo Turner

+44 (0)20 7213 0880

 

 

Peterhouse Capital - Brokers

Lucy Williams / Charles Goodfellow

+44 (0)20 7469 0930

 

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURGPUMWPUPAGMP
12
Date   Source Headline
3rd Jul 202512:55 pmRNSFurther re: Winding-Up Petition
12th Feb 20255:45 pmRNSFurther re: Winding-Up Petition
12th Feb 20257:00 amRNSWinding-Up Petition
19th Dec 202411:35 amRNSFurther re: Winding-Up Petition
26th Nov 202410:00 amRNSWinding-Up Petition
15th Nov 20247:00 amRNSUpdate on €1 million loan
11th Nov 20241:30 pmRNSChange of Registered Office
7th Oct 20247:00 amRNSUpdate on receipt of €1 million loan
21st Aug 20243:30 pmRNSUpdate on receipt of €1 million loan
14th Aug 20247:00 amRNSUpdate on Petition and Related Party Transactions
1st Aug 20241:10 pmRNSWinding-Up Petition
1st Aug 20248:00 amRNSDelay to the publication of accounts & Suspension
15th Jul 20247:00 amRNSSettlement of Fees and Issue of Equity
8th Jul 202410:30 amRNSHolding(s) in Company
2nd Jul 20243:18 pmRNSHolding(s) in Company
2nd Jul 202410:45 amRNSFacility, Cultivation and Market Update
25th Jun 20247:00 amRNSDirectorate Changes
3rd Jun 20247:00 amRNSTotal Voting Rights
16th May 202411:30 amRNSFurther re: Mezzanine Loan
8th May 20249:00 amRNSPlacing & Issue of Equity
1st May 202412:00 pmRNSTotal Voting Rights
22nd Apr 20247:00 amRNSLong Term Loan Agreement
16th Apr 20242:00 pmRNSSettlement of Fees and Issue of Equity
28th Mar 20244:35 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSPart Discharge of Loan & Interest, Issue of Equity
22nd Mar 20247:00 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSSettlement of Fees and Issue of Equity
23rd Jan 20242:00 pmRNSFirst Instalment of EU Grant
17th Jan 202411:00 amRNSLetter of intent for funding with Piraeus Bank S.A
28th Dec 20232:01 pmRNSHalf-year Report
19th Dec 20237:00 amRNSAgreement with The University of Patras
27th Nov 20237:00 amRNSCapital Reorganisation
23rd Nov 20237:00 amRNSNew Company Presentation and Facility Presentation
20th Nov 20234:30 pmRNSResult of General Meeting
17th Nov 20237:00 amRNSTimetable for the Proposed Capital Reorganisation
26th Oct 20237:00 amRNSMezzanine Loan and Posting of Circular
11th Oct 20237:00 amRNSCommencement of Cultivation
7th Sep 20237:00 amRNSNotice of AGM
31st Jul 202310:05 amRNSSuccessful Application for EU Grant
31st Jul 202310:00 amRNSAnnual Report for the period ended 31 March 2023
6th Jul 20234:55 pmRNSRepayment of Convertible Loan Note
13th Jun 20237:00 amRNSSigning of MoU with Demecan Holding
6th Jun 20237:00 amRNSBusiness Update
27th Mar 20237:00 amRNSAppointment of Katherine Fleming to Advisory Board
22nd Mar 20237:00 amRNSMemorandum of Understanding with ELGO-DIMITRA
21st Mar 20232:00 pmRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20234:40 pmRNSSecond Price Monitoring Extn
14th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Feb 202311:05 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.